ArticleNature communications2016

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.

Jacob J Chabon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.